NCT06324461View on ClinicalTrials.gov

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Myocardial Injury
Interventions
DRUG

Dulaglutide 0.75mg subcutaneous injection

Subject randomized into treatment group will receive single subcutaneous dose of Dulaglutide 0.75mg 1 to 14 days prior to surgery

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Duchess of Kent Children's Hospital at Sandy Bay, Hong Kong

RECRUITING

Queen Mary Hospital, Hong Kong

RECRUITING

Tung Wah Hospital, Hong Kong

All Listed Sponsors
collaborator

Research Grants Council, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER